Discover Technozym ADAMTS13 Activity for Your Clinical Laboratory
Posted on: April 24, 2024
This is an archived edition of our email newsletter.
It’s Not Just Support. It’s Solutions.
TECHNOZYM ADAMTS13 ACTIVITY KIT
DiaPharma is pleased to offer the first in vitro diagnostic (IVD) test to receive marketing authorization by the FDA.
The Technozym ADAMTS13 Activity assay is an enzyme-linked immunosorbent assay (ELISA) intended for the qualitative determination of ADAMTS13 activity in platelet poor human citrated plasma. The assay is intended to be used in conjunction with other clinical and laboratory findings as an aid in the diagnosis of thrombotic thrombocytopenic purpura (TTP) in adult and pediatric patients being evaluated for thrombotic microangiopathy (TMA).
DiaPharma is proud to partner with Technoclone to lead the way for better access to this important test, addressing an unmet need for laboratories and patients across the U.S.
Technozym ADAMTS13 Activity Chromogenic ELISA features:
- Calibrators and Controls are traceable to WHO 1st international Standard ADAMTS13 plasma
- No interference by bilirubin, lipemic samples up to 500 mg/dL, or hemolytic samples up to 220 mg/dL
- Straightforward ELISA format
It’s Not Just Support. It’s Solutions.
View our full portfolio of hemostasis assays at diapharma.com or
connect with a DiaPharma scientist to learn more.
DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-01161Rev01